Skip to main content

Advertisement

Log in

Rapidly progressive neurological deterioration in anti-AMPA receptor encephalitis with additional CRMP5 antibodies

  • Brief Communication
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) encephalitis positive for additional onconeural antibodies is rarely reported. Here we report the clinical features of a patient who developed limbic encephalitis with both glutamate receptor 2 (GluR2) and collapsin response mediator protein 5 (CRMP5) antibodies. Brain magnetic resonance imaging revealed multifocal encephalopathy. Chest computed tomography showed a highly suspicious malignant thymoma. He experienced rapid neurological deterioration during hospitalization. This report indicates that the clinical diversity of anti-AMPAR encephalitis and the presence of onconeural antibodies may lead to poor prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Lai M, Hughes EG, Peng X, Zhou L, Gleichman AJ, Shu H, Mata S, Kremens D, Vitaliani R, Geschwind MD, Bataller L, Kalb RG, Davis R, Graus F, Lynch DR, Balice-Gordon R, Dalmau J (2009) AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 65(4):424–434. doi:10.1002/ana.21589

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Hoftberger R, van Sonderen A, Leypoldt F, Houghton D, Geschwind M, Gelfand J, Paredes M, Sabater L, Saiz A, Titulaer MJ, Graus F, Dalmau J (2015) Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients. Neurology 84(24):2403–2412. doi:10.1212/WNL.0000000000001682

    Article  PubMed  PubMed Central  Google Scholar 

  3. Graus F, Saiz A, Lai M, Bruna J, Lopez F, Sabater L, Blanco Y, Rey MJ, Ribalta T, Dalmau J (2008) Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations. Neurology 71(12):930–936. doi:10.1212/01.wnl.0000325917.48466.55

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Hoftberger R, Titulaer MJ, Sabater L, Dome B, Rozsas A, Hegedus B, Hoda MA, Laszlo V, Ankersmit HJ, Harms L, Boyero S, de Felipe A, Saiz A, Dalmau J, Graus F (2013) Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology 81(17):1500–1506. doi:10.1212/WNL.0b013e3182a9585f

    Article  PubMed  PubMed Central  Google Scholar 

  5. Tuzun E, Dalmau J (2007) Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist 13(5):261–271. doi:10.1097/NRL.0b013e31813e34a5

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by grant from Natural Science Foundation of China (No. 81301007 to Jie Qin).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shilei Sun.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

S. Yang and J. Qin contributed equally to this article.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, S., Qin, J., Li, J. et al. Rapidly progressive neurological deterioration in anti-AMPA receptor encephalitis with additional CRMP5 antibodies. Neurol Sci 37, 1853–1855 (2016). https://doi.org/10.1007/s10072-016-2680-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-016-2680-0

Keywords

Navigation